UPCC 08024 Remote Vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)

UPCC 08024 Remote Vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)
Administratively Closed
18 years - 99 years
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to learn about differences between in-person and/or remote visits designed to help people to quit smoking with a combination of nicotine replacement patches and lozenges. We aim to compare the remote and in-person groups based on their accrual and retention rates as well as other key metrics of trial quality. We will also examine the impact of trial efficiency and quality on sub-groups that experience health inequities.

Detailed description of study

If you agree to join the study you will be asked to:

  • Attend 1 Intake session which will last about 1 hour
  • Attend 5 Treatment and Assessment sessions which are 30-60 minutes each
    • At each Treatment and Assessment session you will provide a breath sample, complete surveys about your experiences, and review your smoking behavior and medication usage
  • Use the 8 weeks of combination nicotine replacement therapy (patch and lozenge) that we will provide to you

    Whether your visits are remote or in-person will be determined randomly by a computer
    program.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Clinical Research
  • Age: 18 years - 99 years
  • Gender: All
Updated on 22 Jul 2026. Study ID: 24-2278

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center